Bibliometrics and scientometrics in India: An overview of studies during 1995-2014, Part I: Indian publication output and its citation impact

An analysis of 801 papers published in the area of bibliometrics and scientometrics during 1995-2014 indicates a steep increase in the number of papers published by Indian researchers as compared to the number of papers published during 1970-1994. This indicates a growing interest of Indian scholars in scientometrics and bibliometrics. The paper provides several reasons for this steep increase. The main focus of research is on bibliometric assessment of India and other countries followed by cross national assessment and bibliometric analysis of individual journals. CSIR-NISTADS is the top producing institute contributing about one-third (31.4%) of the total output followed by the output of Bhabha Atomic Research Centre and CSIR-NISCAIR. The distribution of citation data indicates that about one-fifth (21.7%) papers remained uncited. The paper identifies journals in which these uncited papers were published. Only 15% papers were cited more than 20 times. Most of the prolific authors as well as highly cited authors were from the institutions belonging to the Council of Scientific and Industrial Research. Among all authors B.M. Gupta (CSIR-NISTADS) produced the highest number of papers, but the impact as seen in terms of citation per paper and relative citation impact, S. Arunachalam (MSSRF) topped the list

Bibliometrics and scientometrics in India: An overview of studies during 1995-2014Part II: Contents of the articles in terms of disciplines and their bibliometric aspects

This part of the study highlights the contents of the published articles in terms of various disciplines or sub-disciplines and the bibliometric aspects discussed in these articles. The analysis of 902 papers published by Indian scholars during1995-2014 indicates that the main focus of bibliometrics/scientometrics is on assessment of science and technology in India in different sub-disciplines including contributions by Indian states and other individual countries followed by bibliometric analysis of individual journals. Papers dealing with bibliometric laws received a low priority as compared to other subdisciplines of bibliometrics/scientometrics. The analysis of data indicates that the share of theoretical studies using mathematical and statistical techniques which were missing in the earlier period (1970-1994) has increased during 1995-2014. The field of medicine as a discipline received the highest attention as compared to other disciplines

Scientometrics of Indian crop science research as reflected by the coverage inScopus, CABI and ISA databases during 2008-2010

The paper analyses scientific output of India in the discipline of crop sciences as reflected by the coverage of scientificoutput in three different databases i.e. SCOPUS, CAB Abstracts and ISA (Indian Science Abstracts) during 2008-2010. Theanalysis indicates that highest number of papers was published on rice and wheat crop. Agricultural universities andinstitutions under the aegis of Indian Council of Agricultural Research (ICAR) were most productive institutions. Most ofthe papers were published in Indian journals with low impact factor. Environment and Ecology, Indian Journal ofAgricultural Sciences and Research on Crops were the most preferred journals used by the Indian scientists. The majorresearch is focused on ‘genetics and plant breeding’ followed by ‘soil, climate and environmental aspects’ and ‘agronomicaspects’. The authorship pattern reveals that co-authored papers accounted for 72% of total output

Scientometrics of cereal crops research in India as reflected through Indian Science Abstracts and CAB Abstracts during 1965-2010

The paper analyses publication output of India on cereal crops as reflected by its coverage in Indian Science Abstracts (ISA) and CAB Abstracts during 1965-2010.The analysis indicates that highest number of papers (43.80%) was published on rice, followed by wheat (24.28%). Agricultural universities and institutions under aegis of Indian Council of Agricultural Research (ICAR) were most productive. Most of the papers were published in Indian journals with low impact factor. The highest number of papers was published in Indian Journal of Agricultural Sciences, followed by Indian Journal of Agronomy, Madras Agricultural Journaland Journal of Maharashtra Agricultural University. Indian Agricultural Research Institute, New Delhi,Tamil Nadu Agricultural University, Coimbatoreand Punjab Agricultural University, Ludhianacontributed about 7% of papers each. The major research was focused on ‘genetic and plant breeding’ (28.2%) followed by ‘agronomic aspects’ (27.9%) and pest, diseases and pest control (19.7%). The authorship pattern reveals that co-authored papers accounted for 90% of total output. Citation analysis of the study using Google scholar reveals that 57% of the papers remained uncited and 36.8% papersreceived citations ranging from 1 to 10.Highest number of citations were received by papers published in Indian Journal of Agronomy(1446), followed by Indian Journal of Agricultural Science (1211), Euphytica (1109) and Theoretical and Applied Genetics (1000

A comparative study of Kigelia pinnata fruit extracts in terms of antimutagenic potential and antimicrobial efficacy against antibiotic-resistant microbial strains

224-233In recent years, antibiotic-resistant microbes have become a serious concern which needs proper attention either to solve the problem or to find out the solution to treat it. In this study, antibiotic resistant strains of Pseudomonas, Enterococcus, and Escherichia coli (E. coli) were used to assess the antimicrobial potential of Kigelia pinnata fruit extract. Further, antimutagenic potential of Kigelia pinnata fruit extract was also assessed by Ames assay using Salmonella typhimurium strain TA 98 and TA 100. In antimicrobial assay, only chloroform, ethanol and hexane extract was found to produce clear zone diameter between 1.08±0.1 to 2.1±0.2 mm. Results of minimum inhibitory concentration revealed the effectiveness of chloroform extract on Pseudomonas, Enterococcus and E.coli at 1.8 mg/mL concentration. However, better antimicrobial activity was found with ethanol extracts at 2.1x10-2 mg/mL concentration revealing the effectiveness of the low dose of ethanol in killing the antimicrobial resistant strains. In the time-kill test method, chloroform extract of K. pinnata was found to be most effective in reducing 98-99% test microbial population at both dilutions in 30 min. Antimutagenicity test showed the equal potential of chloroform and ethanol extracted Kigelia fruit sample in reducing the number of revertants. Kigelia fruit extract (1000 μL) dose can reduce the mutagens at 5 μg/plate level but not at 10 μg/plate dose level. Further research will open the new scope in the field of development of herbal antimicrobials and antimutagenic compound for treating antibiotic-resistant microbes and cancer

YOGA PRACTICE AND BIOCHEMICAL AND PHYSIOLOGICAL ALTERATIONS IN NORMAL SUBJECTS

ABSTRACTObjective: To assess the effect of 45 minute yogic kriya (Surya Namaskar and Kapalbhati) for 30 days on various physiological and biochemicalparameters.Methods: About 20 Nursing College students of the Santosh Medical University, Ghaziabad, between the age group 17 and 21 years volunteered toparticipate in the study. They were divided into two Groups A and B. Group A students including 10 students in each group were subjected to 30 daysyoge kriya for 45 minutes for 6 days in a week. Statistical analysis: A student's t-test was used for comparing the means of pre- and post-yoga resultsof various parameters.Results: No significant difference was found in systolic blood pressure, pulse, body mass index, hemoglobin except for fasting blood sugar and diastolicblood pressure (p<0.001) among the yoga subject while comparing with baseline values and control.Keywords: Yoga, Biochemical alterations, Physiological alterations, Surya Namaskar and Kapal Bhati

Medium optimization for the production of lipstatin by Streptomyces toxytricini using full factorial design of experiment

Abstract: Full factorial design of experiment for medium optimization was employed for lipstatin production by Streptomyces toxytricini in shake flask study. The full factorial DOE was very much effective in screening of nutritional parameters within the stipulated time frame in a limited number of experiments. A maximum lipstatin production was achieved 3.290 g/l with the following optimized factors: soya flour 35g/l and soya oil 25g/l. Validation experiments were also carried out to verify the adequacy and the accuracy of the model. The results also give a scope for large scale fermentation of lipstatin production. [Luthra, U., Kumar, H., Kulshreshtha, N., Tripathi, A., Trivedi, A., Khadpekar, S., Chaturvedi, A. and Dubey, R.C. Medium optimization for the production of lipstatin by Streptomyces toxytricini using full factorial design of experiment. Nat Sci 2013;1

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

As mortality rates decline, life expectancy increases, and populations age, non-fatal outcomes of diseases and injuries are becoming a larger component of the global burden of disease. The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016

Background: A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0-100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0-100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings In 2016, HAQ Index performance spanned from a high of 97\ub71 (95% UI 95\ub78-98\ub71) in Iceland, followed by 96\ub76 (94\ub79-97\ub79) in Norway and 96\ub71 (94\ub75-97\ub73) in the Netherlands, to values as low as 18\ub76 (13\ub71-24\ub74) in the Central African Republic, 19\ub70 (14\ub73-23\ub77) in Somalia, and 23\ub74 (20\ub72-26\ub78) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91\ub75 (89\ub71-93\ub76) in Beijing to 48\ub70 (43\ub74-53\ub72) in Tibet (a 43\ub75-point difference), while India saw a 30\ub78-point disparity, from 64\ub78 (59\ub76-68\ub78) in Goa to 34\ub70 (30\ub73-38\ub71) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4\ub78-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20\ub79-point to 17\ub70-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17\ub72-point to 20\ub74-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle- SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view-and subsequent provision-of quality health care for all populations

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016

Copyright © 2018 The Author(s). Published by Elsevier Ltd. Background A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0-100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0-100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings In 2016, HAQ Index performance spanned from a high of 97·1 (95% UI 95·8-98·1) in Iceland, followed by 96·6 (94·9-97·9) in Norway and 96·1 (94·5-97·3) in the Netherlands, to values as low as 18·6 (13·1-24·4) in the Central African Republic, 19·0 (14·3-23·7) in Somalia, and 23·4 (20·2-26·8) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91·5 (89·1-93·6) in Beijing to 48·0 (43·4-53·2) in Tibet (a 43·5-point difference), while India saw a 30·8-point disparity, from 64·8 (59·6-68·8) in Goa to 34·0 (30·3-38·1) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4·8-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20·9-point to 17·0-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17·2-point to 20·4-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle- SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view - and subsequent provision - of quality health care for all populations